The agreement stems from the two companies having concluded on February 6 this year a MOU on beginning considerations for business partnership, after which they began discussing, among other topics, the dissemination of vehicle electrification technologies in India.

Roche announced today that the US FDA approved Gazyva® (obinutuzumab) in combination with chemotherapy, followed by Gazyva alone in those who responded, for people with previously untreated advanced follicular lymphoma (stage II bulky, III or IV).

Multi-touch gestures possible even in small, affordable vehicles.

Under the agreement, Roche is acquiring all shares of the company.

Sberbank announces the signing of a deal to acquire a block of shares in VisionLabs, a global leader of the facial recognition market.